Recens Medical
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
RecensMedical develops medical devices that cool living tissue with high precision, targeting conditions such as acne, eczema, psoriasis, and hair loss, areas where heat-based treatments like lasers cannot be used.
Its technology uses the physical expansion of a liquid cryogenic refrigerant to control cooling temperature rapidly and precisely, overcoming the limited accuracy of conventional cold-therapy methods. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company's core business is built around this proprietary precision-cooling platform as its single underlying technology.
Summary is AI-generated and may contain errors · figures from DART filings
Recens Medical in five facts
What does Recens Medical do?
RecensMedical develops medical devices that cool living tissue with high precision, targeting conditions such as acne, eczema, psoriasis, and hair loss, areas where heat-based treatments like lasers cannot be used.
Where is Recens Medical listed and in which sector?
Recens Medical (Korean name: 리센스메디컬) trades under KRX code 394420 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Recens Medical?
Its market capitalisation was US$55.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Recens Medical's latest annual revenue and operating profit?
For fiscal year 2025, Recens Medical reported revenue of US$6.7M, an operating loss of US$8M and a net loss of US$14.4M, per its annual report on DART (data retrieved from DART on 2026-10-02).
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.